Omada Health Inc. Marks Successful IPO
Omada Health Inc. has wrapped up its first day of trading after successfully raising $150 million in its initial public offering.
The company’s shares experienced a notable increase of 21%, closing at $23 on Friday in New York. At one point during the session, the stock had surged by about 49%. According to filings with the U.S. Securities and Exchange Commission, Omada, which is based in San Francisco, initially priced its shares between $18 and $20 before selling 19.9 million shares.
This transaction positions Omada with a market valuation of approximately $1.3 billion, calculated based on the number of outstanding shares included in the filing.
Bloomberg data indicates that IPOs this year have collectively raised around $24.9 billion. Healthcare start-up stocks listed on U.S. exchanges have, on average, increased by about 18% so far.
Recently, Hinge Health Inc., a competitor in the digital physiotherapy sector, raised $503 million and saw its stock rise roughly 19% since going public.
Reports state that Omada’s offering concluded with demand exceeding available shares by more than 15 times, leading to allocations being directed towards a select group of investors.
About Omada Health
Founded in 2011, Omada provides virtual care services designed to assist individuals managing chronic conditions like diabetes and obesity. Users monitor important health metrics such as weight and blood pressure through the company’s platform, which includes mobile applications.
Unlike many competitors in the digital health field, Omada does not provide GLP-1 medications for weight loss. Instead, their programs focus on support, coaching, and nutritional guidance to help individuals manage their weight effectively without reliance on medication.
Out of Omada’s 679,000 members, about 50,000 have engaged with their GLP-1 services. This area has been a relatively new venture for the company, especially following their partnership with Cigna Group’s Express Scripts.
Using AI technology, Omada enhances the virtual care experience for clients, although the approach remains fundamentally human-centered. Members have expressed a desire for personal connections rather than automated interactions. As one representative noted, “I haven’t seen anyone who feels accountable to ChatGPT yet.”
Omada serves over 2,000 clients, including various employers and healthcare systems, and maintains a total of 679,000 registered members across its programs.
Shareholder Information
Revelation Partners holds the largest stake in Omada, owning 10.9% of the company pre-offer. Other significant shareholders include USVP (9.9%), Andreessen Horowitz (9.6%), and FMR (9.3%). Previously, the company achieved a valuation exceeding $1 billion in a funding round led by Fidelity Management & Research Co.
Recent financial reports indicate that Omada incurred a net loss of $9.4 million on revenues nearing $55 million in the first quarter of 2025, compared to a net loss of about $19 million with revenues of $35.1 million in the same timeframe the previous year.
The underwriting for the IPO was managed by Morgan Stanley, Goldman Sachs, and JPMorgan Chase. Omada’s shares are trading on the NASDAQ under the symbol OMDA.
